The Future Looks Bright For Cialis
The pharmaceutical giant Eli Lilly has issued a statement regarding its erectile dysfunction medication Cialis and are extremely bullish about its future prospects and the possibility of gaining a greater market share of the world wide impotence drugs market. In the first three financial quarters of 2008 Cialis has already generated over $1 billion in sales for Eli Lilly and it looks like this year will be a record year. The Cialis drug is now available in over 100 different countries worldwide and has managed to gain the largest market share in twenty of them.
Improve your love life with generic Cialis or Viagra
Generic drugs wear this label because they reach the market under their chemical or generic name. This means that they are identical to the brand name drugs in everything but the name. The FDA (Federal Food and Drug Administration) verifies all generic drugs to offer a guarantee that they treat the illness with the same safety, effectiveness and strength levels as their brand name equivalent.
Generic drugs manufacturers must get WHO’s (World Health Organization) approval. Sometimes, the same pharmaceutical company that makes the brand drug also produces its generic version; in other cases, the company specializes in producing generic drugs.
Cialis May Help Ease Pulmonary Hypertension
Cialis (tadalafil), a drug used to treat erectile dysfunction, appears effective in treating pulmonary hypertension, researchers report.
Pulmonary hypertension is caused by high blood pressure in the arteries that supply the lungs with blood. People who suffer from the condition can become tired, dizzy and short of breath, because the arteries feeding the lungs constrict and reduce the supply of oxygenated blood being circulating throughout the body.
But Cialis “was found to improve exercise capacity, health-related quality of life, delay time to clinical worsening, and improve hemodynamic [blood-linked] parameters of disease severity,” said lead researcher Dr. Robyn J. Barst, a professor of pediatrics at Columbia University College of Physicians & Surgeons in New York City. The drug was also well-tolerated, she added.
United licenses drug indication to Lilly
Are you ready for an erectile dysfunction drug revamped to treat high blood pressure? Eli Lilly and United Therapeutics are betting big on it. The two companies have inked a deal to commercialize the active ingredient in Cialis–tadalafil–for pulmonary arterial hypertension. That indication is currently under review by watchdogs in the U.S., Canada, Mexico, Japan, and the E.U.
Under the deal, United Therapeutics will pony up $150 million for exclusive rights to tadalafil for the hypertension use in the U.S. The company will also get a manufacturing-and-supply deal for its money: Lilly will make the molecule for United Therapeutics and will handle all the regulatory and patent details.
Healthbeatrss Cialis may help reduce UTI symptoms
An enlarged prostate is usually associated with problematic urinary problems for men, but a drug used for another issue may be able to help.
New research funded by Eli Lilly shows a daily dose of the drug Cialis helped men ease lower urinary tract symptoms including increased urination frequency.
Currently, the drug is only approved for treating erectile dysfunction. But, with about 50 percent of men over 50 suffering from some version of this problem, the study suggests a large potential market for erectile dysfunction drugs.
The results of the study will appear in the October edition of the Journal of Urology.
